Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs

Journal of Molecular Biology

Volumn 357, Issue 1, 2006, Pages 82-99

  Prabakaran, Ponraj ^a   Gan, Jianhua ^a   Wu, You Qiang ^a   Zhang, Mei Yun ^a,b   Dimitrov, Dimiter S ^a   Ji, Xinhua ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

Antibody; Crystal structure; gp120; HIV; Vaccine

Indexed keywords

CD4 ANTIGEN; HYDROGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB) FRAGMENT; ISOLEUCINE; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANTIBODY COMBINING SITE; ANTIGEN STRUCTURE; ARTICLE; CONTROLLED STUDY; CROSS LINKING; CROSS REACTION; CRYSTAL STRUCTURE; HEAVY CHAIN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROGEN BOND; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN MOTIF;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33644768318     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2005.12.062     Document Type: Article

References (78)

1. D.S. Dimitrov Virus entry: molecular mechanisms and biomedical applications Nature Rev. Microbiol. 2 2004 109 122
2. A.E. Smith, and A. Helenius How viruses enter animal cells Science 304 2004 237 242
3. D.R. Burton Antibodies, viruses and vaccines Nature Rev. Immunol. 2 2002 706 713
4. F. Ferrantelli, and R.M. Ruprecht Neutralizing antibodies against HIV - back in the major leagues? Curr. Opin. Immunol. 14 2002 495 502
5. R.S. Veazey, R.J. Shattock, M. Pope, J.C. Kirijan, J. Jones, and Q. Hu Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120 Nature Med. 9 2003 343 346
6. C.F. Barbas III, T.A. Collet, W. Amberg, P. Roben, J.M. Binley, and D. Hoekstra Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries J. Mol. Biol. 230 1993 812 823
7. D.R. Burton, C.F. Barbas III, M.A. Persson, S. Koenig, R.M. Chanock, and R.A. Lerner A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals Proc. Natl Acad. Sci. USA 88 1991 10134 10137
8. D.R. Burton, J. Pyati, R. Koduri, S.J. Sharp, G.B. Thornton, and P.W. Parren Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody Science 266 1994 1024 1027
9. P. Roben, J.P. Moore, M. Thali, J. Sodroski, C.F. Barbas III, and D.R. Burton Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1 J. Virol. 68 1994 4821 4828
10. M.B. Zwick, P.W. Parren, E.O. Saphire, S. Church, M. Wang, and J.K. Scott Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120 J. Virol. 77 2003 5863 5876
11. R. Pantophlet, S.E. Ollmann, P. Poignard, P.W. Parren, I.A. Wilson, and D.R. Burton Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120 J. Virol. 77 2003 642 658
12. P.W. Parren, P. Fisicaro, A.F. Labrijn, J.M. Binley, W.P. Yang, and H.J. Ditzel In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelope J. Virol. 70 1996 9046 9050
13. D.D. Ho, J.A. McKeating, X.L. Li, T. Moudgil, E.S. Daar, N.C. Sun, and J.E. Robinson Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody J. Virol. 65 1991 489 493
14. A. Pinter, W.J. Honnen, M.E. Racho, and S.A. Tilley A potent, neutralizing human monoclonal antibody against a unique epitope overlapping the CD4-binding site of HIV-1 gp120 that is broadly conserved across North American and African virus isolates AIDS Res. Hum. Retroviruses 9 1993 985 996
15. M. Thali, U. Olshevsky, C. Furman, D. Gabuzda, M. Posner, and J. Sodroski Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody J. Virol. 65 1991 6188 6193
16. J.P. Moore, and J. Sodroski Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein J. Virol. 70 1996 1863 1872
17. S.A. Tilley, W.J. Honnen, M.E. Racho, M. Hilgartner, and A. Pinter A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activity Res. Virol. 142 1991 247 259
18. M. Thali, C. Furman, D.D. Ho, J. Robinson, S. Tilley, A. Pinter, and J. Sodroski Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein J. Virol. 66 1992 5635 5641
19. S. Laal, S. Burda, M.K. Gorny, S. Karwowska, A. Buchbinder, and S. Zolla-Pazner Synergistic neutralization of human immunodeficiency virus type 1 by combinations of human monoclonal antibodies J. Virol. 68 1994 4001 4008
20. M.Y. Zhang, X. Xiao, I.A. Sidorov, V. Choudhry, F. Cham, and P.F. Zhang Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody J. Virol. 78 2004 9233 9242
21. M.Y. Zhang, Y. Shu, S. Phogat, X. Xiao, F. Cham, and P. Bouma Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library J. Immunol. Methods 283 2003 17 25
22. E.O. Saphire, P.W. Parren, R. Pantophlet, M.B. Zwick, G.M. Morris, and P.M. Rudd Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design Science 293 2001 1155 1159
23. M.P. D'Souza, G. Milman, J.A. Bradac, D. McPhee, C.V. Hanson, and R.M. Hendry Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodies AIDS 9 1995 867 874
24. M.P. D'Souza, D. Livnat, J.A. Bradac, and S.H. Bridges Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: performance criteria for selecting candidate antibodies for clinical trials. AIDS Clinical Trials Group Antibody Selection Working Group J. Infect. Dis. 175 1997 1056 1062
25. P.D. Kwong, M.L. Doyle, D.J. Casper, C. Cicala, S.A. Leavitt, and S. Majeed HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites Nature 420 2002 678 682
26. P.D. Kwong, R. Wyatt, J. Robinson, R.W. Sweet, J. Sodroski, and W.A. Hendrickson Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody Nature 393 1998 648 659
27. C.C. Huang, M. Venturi, S. Majeed, M.J. Moore, S. Phogat, and M.Y. Zhang Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120 Proc. Natl Acad. Sci. USA 101 2004 2706 2711
28. M. Moulard, S.K. Phogat, Y. Shu, A.F. Labrijn, X. Xiao, and J.M. Binley Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes Proc. Natl Acad. Sci. USA 99 2002 6913 6918
29. R. Darbha, S. Phogat, A.F. Labrijn, Y. Shu, Y. Gu, and M. Andrykovitch Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope Biochemistry 43 2004 1410 1417
30. G. Ofek, M. Tang, A. Sambor, H. Katinger, J.R. Mascola, R. Wyatt, and P.D. Kwong Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope J. Virol. 78 2004 10724 10737
31. M.B. Zwick, H.K. Komori, R.L. Stanfield, S. Church, M. Wang, and P.W. Parren The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5 J. Virol. 78 2004 3155 3161
32. R.M. Cardoso, M.B. Zwick, R.L. Stanfield, R. Kunert, J.M. Binley, and H. Katinger Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41 Immunity 22 2005 163 173
33. H. Choe, W. Li, P.L. Wright, N. Vasilieva, M. Venturi, and C.C. Huang Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120 Cell 114 2003 161 170
34. S.H. Xiang, M. Farzan, Z. Si, N. Madani, L. Wang, and E. Rosenberg Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody J. Virol. 79 2005 6068 6077
35. R.A. Wilkinson, C. Piscitelli, M. Teintze, L.A. Cavacini, M.R. Posner, and C.M. Lawrence Structure of the Fab fragment of F105, a broadly reactive anti-human immunodeficiency virus (HIV) antibody that recognizes the CD4 binding site of HIV type 1 gp120 J. Virol. 79 2005 13060 13069
36. B. Chen, E.M. Vogan, H. Gong, J.J. Skehel, D.C. Wiley, and S.C. Harrison Structure of an unliganded simian immunodeficiency virus gp120 core Nature 433 2005 834 841
37. G.N. Ramachandran, and V. Sasisekharan Conformation of polypeptides and proteins Advan. Protein Chem. 23 1968 283 438
38. E. Milner-White, B.M. Ross, R. Ismail, K. Belhadj-Mostefa, and R. Poet One type of gamma-turn, rather than the other gives rise to chain-reversal in proteins J. Mol. Biol. 204 1988 777 782
39. M. Kontou, D.D. Leonidas, E.H. Vatzaki, P. Tsantili, A. Mamalaki, and N.G. Oikonomakos The crystal structure of the Fab fragment of a rat monoclonal antibody against the main immunogenic region of the human muscle acetylcholine receptor Eur. J. Biochem. 267 2000 2389 2397
40. K. Poulas, E. Eliopoulos, E. Vatzaki, J. Navaza, M. Kontou, and N. Oikonomakos Crystal structure of Fab198, an efficient protector of the acetylcholine receptor against myasthenogenic antibodies Eur. J. Biochem. 268 2001 3685 3693
41. D.R. Davies, E.A. Padlan, and D.M. Segal Three-dimensional structure of immunoglobulins Annu. Rev. Biochem. 44 1975 639 667
42. D.R. Davies, and H. Metzger Structural basis of antibody function Annu. Rev. Immunol. 1 1983 87 117
43. L.M. Amzel, and R.J. Poljak Three-dimensional structure of immunoglobulins Annu. Rev. Biochem. 48 1979 961 997
44. J. Novotny, R. Bruccoleri, J. Newell, D. Murphy, E. Haber, and M. Karplus Molecular anatomy of the antibody binding site J. Biol. Chem. 258 1983 14433 14437
45. D. Rothlisberger, A. Honegger, and A. Pluckthun Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability J. Mol. Biol. 347 2005 773 789
46. E. Vargas-Madrazo, and E. Paz-Garcia An improved model of association for VH-VL immunoglobulin domains: asymmetries between VH and VL in the packing of some interface residues J. Mol. Recogn. 16 2003 113 120
47. C. Chothia, J. Novotny, R. Bruccoleri, and M. Karplus Domain association in immunoglobulin molecules. The packing of variable domains J. Mol. Biol. 186 1985 651 663
48. G.H. Cohen, S. Sheriff, and D.R. Davies Refined structure of the monoclonal antibody HyHEL-5 with its antigen hen egg-white lysozyme Acta Crystallog. sect. D 52 1996 315 326
49. G.H. Cohen, E.W. Silverton, E.A. Padlan, F. Dyda, J.A. Wibbenmeyer, R.C. Willson, and D.R. Davies Water molecules in the antibody-antigen interface of the structure of the Fab HyHEL-5-lysozyme complex at 1.7 Å resolution: comparison with results from isothermal titration calorimetry Acta Crystallog. sect. D 61 2005 628 633
50. J.P. Schuermann, M.T. Henzl, S.L. Deutscher, and J.J. Tanner Structure of an anti-DNA fab complexed with a non-DNA ligand provides insights into cross-reactivity and molecular mimicry Proteins: Struct. Funct. Genet. 57 2004 269 278
51. J. Tormo, E. Stadler, T. Skern, H. Auer, O. Kanzler, and C. Betzel Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2 Protein Sci. 1 1992 1154 1161
52. B. Al-Lazikani, A.M. Lesk, and C. Chothia Standard conformations for the canonical structures of immunoglobulins J. Mol. Biol. 273 1997 927 948
53. Kabat, E. A., Wu, T. T., Perry, H. M., Gottesmann, K. S. & Foeller, C. (1991). Sequences of Proteins of Immunological Interest. NIH Publication no. 91-3242, US Department of Health and Human Services.
54. I.M. Tomlinson, J.P. Cox, E. Gherardi, A.M. Lesk, and C. Chothia The structural repertoire of the human V kappa domain EMBO J. 14 1995 4628 4638
55. M.P. Lefranc, V. Giudicelli, Q. Kaas, E. Duprat, J. Jabado-Michaloud, and D. Scaviner IMGT, the international ImMunoGeneTics information system Nucl. Acids Res. 33 2005 D593 D597
56. K.D. Pruitt, T. Tatusova, and D.R. Maglott NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins Nucl. Acids Res. 33 2005 D501 D504
57. V. Morea, A.M. Lesk, and A. Tramontano Antibody modeling: implications for engineering and design Methods 20 2000 267 279
58. V. Morea, A. Tramontano, M. Rustici, C. Chothia, and A.M. Lesk Conformations of the third hypervariable region in the VH domain of immunoglobulins J. Mol. Biol. 275 1998 269 294
59. K. Furukawa, H. Shirai, T. Azuma, and H. Nakamura A role of the third complementarity-determining region in the affinity maturation of an antibody J. Biol. Chem. 276 2001 27622 27628
60. H. Shirai, A. Kidera, and H. Nakamura Structural classification of CDR-H3 in antibodies FEBS Letters 399 1996 1 8
61. H. Shirai, A. Kidera, and H. Nakamura H3-rules: identification of CDR-H3 structures in antibodies FEBS Letters 455 1999 188 197
62. J.H. Wang, Y.W. Yan, T.P. Garrett, J.H. Liu, D.W. Rodgers, and R.L. Garlick Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains Nature 348 1990 411 418
63. H. Kaur, and G.P. Raghava Prediction of alpha-turns in proteins using PSI-BLAST profiles and secondary structure information Proteins: Struct. Funct. Genet. 55 2004 83 90
64. R.M. MacCallum, A.C. Martin, and J.M. Thornton Antibody-antigen interactions: contact analysis and binding site topography J. Mol. Biol. 262 1996 732 745
65. C.C. Huang, F. Stricher, L. Martin, J.M. Decker, S. Majeed, and P. Barthe Scorpion-toxin mimics of CD4 in complex with human immunodeficiency virus gp120 crystal structures, molecular mimicry, and neutralization breadth Structure (Camb) 13 2005 755 768
66. J. Janin Assessing predictions of protein-protein interaction: the CAPRI experiment Protein Sci. 14 2005 278 283
67. H. Lei, and Y. Duan Incorporating intermolecular distance into protein-protein docking Protein Eng. Des. Sel. 17 2004 837 845
68. C.F. Barbas, D.R. Burton, J.K. Scott, and G.J. Silverman Phage Display: A Laboratory Manual 2001 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
69. Z. Otwinowski, and W. Minor Processing of X-ray diffraction data collected in oscillation mode Macromol. Crystallog. 276 1997 307 326
70. J. Navaza Implementation of molecular replacement in AMoRe Acta Crystallog. sect. D 7 2001 1367 1372
71. W.F. Anderson, M. Cygler, R.P. Braun, and J.S. Lee Antibodies to DNA Bioessays 8 1988 69 74
72. A. Cauerhff, B.C. Braden, J.G. Carvalho, R. Aparicio, I. Polikarpov, J. Leoni, and F.A. Goldbaum Three-dimensional structure of the Fab from a human IgM cold agglutinin J. Immunol. 165 2000 6422 6428
73. T.A. Jones, J.Y. Zou, S.W. Cowan, and M. Kjeldgaard Improved methods for building protein models in electron density maps and the location of errors in these models Acta Crystallog. sect. A 47 1991 110 119
74. A.T. Brunger, P.D. Adams, and L.M. Rice New applications of simulated annealing in X-ray crystallography and solution NMR Structure 5 1997 325 336
75. R.A. Laskowski, M.W. Macarthur, D.S. Moss, and J.M. Thornton Procheck - a program to check the stereochemical quality of protein structures J. Appl. Crystallog. 26 1993 283 291
76. G. Vriend WHAT IF: a molecular modeling and drug design program J. Mol. Graph. 8 52-6 1990 29
77. P. Carter, V.I. Lesk, S.A. Islam, and M.J. Sternberg Protein-protein docking using 3D-Dock in rounds 3, 4, and 5 of CAPRI Proteins: Struct. Funct. Genet. 60 2005 281 288
78. R.M. Esnouf An extensively modified version of MolScript that includes greatly enhanced coloring capabilities J. Mol. Graph. Modelling 15 1997 132 134